Nath Bio-Genes (India) Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 284 | 53.95 | 37.35 |
| Operating Expense | 241.27 | 46.20 | 29.36 |
| Net Profit | 38.21 | 4.71 | 2.66 |
| Net Profit Margin | 13.45 | 8.73 | 7.12 |
| Earning Per Share | 20.06 | 2.12 | 1.34 |
| EBIDTA | 42.74 | 7.76 | 8 |
| Effective Tax Rate | 1.54 | 8.13 | 14.27 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 284.00 |
| Operating Expense | 241.27 |
| Net Profit | 38.21 |
| Net Profit Margin | 13.45 |
| Earning Per Share | 20.06 |
| EBIDTA | 42.74 |
| Effective Tax Rate | 1.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 362.31 | 332.62 | 301.29 |
| Operating Expenses Annual | 310.01 | 282.24 | 252.40 |
| Operating Profit Annual | 57.56 | 54.49 | 49.45 |
| Interest Annual | 9.65 | 9.10 | 10.12 |
| Depreciation | 2.16 | 1.66 | 1.37 |
| Net Profit Annual | 42.14 | 40.18 | 35.17 |
| Tax Annual | 1.98 | 1.95 | 1.15 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 362.31 |
| Operating Expenses Annual | 310.01 |
| Operating Profit Annual | 57.56 |
| Interest Annual | 9.65 |
| Depreciation | 2.16 |
| Net Profit Annual | 42.14 |
| Tax Annual | 1.98 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 75.50 | 37.98 | 4.17 |
| Cash Flow from Operations | 26.80 | 74.72 | 38.37 |
| Cash Flow from Investing | -4.05 | -27.40 | -2.88 |
| Cash Flow from Financing | -10.62 | -9.81 | -1.67 |
| Cash Flow at the End | 87.63 | 75.50 | 37.98 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 75.50 |
| Cash Flow from Operations | 26.80 |
| Cash Flow from Investing | -4.05 |
| Cash Flow from Financing | -10.62 |
| Cash Flow at the End | 87.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 15.92 | 16.41 | 16.44 |
| PBIT Margin (%) | 14.87 | 15.43 | 15.44 |
| PBT Margin (%) | 13.34 | 13.75 | 13.93 |
| Net PROFIT Margin (%) | 11.63 | 12.08 | 11.67 |
| Return On Networth / Equity (%) | 6.69 | 6.79 | 6.31 |
| Return On Networth /Employed (%) | 7.25 | 7.31 | 7.06 |
| Return On Assets (%) | 5.70 | 5.68 | 5.37 |
| Total Debt / Equity (X) | 0.17 | 0.18 | 0.18 |
| Asset Turnover Ratio (%) | 0.49 | 0.47 | 0.46 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 15.92 |
| PBIT Margin (%) | 14.87 |
| PBT Margin (%) | 13.34 |
| Net PROFIT Margin (%) | 11.63 |
| Return On Networth / Equity (%) | 6.69 |
| Return On Networth /Employed (%) | 7.25 |
| Return On Assets (%) | 5.70 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 250.23 | 249.45 | 244.38 |
| Total Current Assets Annual | 680.55 | 568.52 | 520.99 |
| Non Current Assets Annual | 336.32 | 308.57 | 271.98 |
| Total Shareholders Funds Annual | 648.67 | 610.66 | 573.35 |
| Total Assets Annual | 1,016.87 | 877.08 | 792.97 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 250.23 |
| Total Current Assets Annual | 680.55 |
| Non Current Assets Annual | 336.32 |
| Total Shareholders Funds Annual | 648.67 |
| Total Assets Annual | 1,016.87 |
EPS (INR)
Expected
19.62
Reported
19.58
Surprise
-0.20%
Mar 2025
EPS beaten by -0.20%
Dec 2024
EPS beaten by -46.15%
Sep 2024
EPS beaten by -4.32%
